Published in Semin Cell Dev Biol on December 01, 2015
Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways. Front Physiol (2016) 0.75
Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation. Oxid Med Cell Longev (2017) 0.75
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia. Sci Rep (2017) 0.75
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet (2003) 53.59
Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell (1999) 19.48
A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell (1998) 18.32
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A (2003) 17.10
Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature (2002) 14.37
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol (2001) 10.85
AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol (2012) 10.42
Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell (2004) 8.58
Interactions between motoneurones and muscles in respect of the characteristic speeds of their responses. J Physiol (1960) 8.55
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A (2007) 8.23
FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab (2007) 8.05
Definition and classification of cancer cachexia: an international consensus. Lancet Oncol (2011) 7.78
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 7.15
Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol (2005) 7.11
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J (2004) 7.02
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol (2011) 6.83
Mitochondrial dynamics and apoptosis. Genes Dev (2008) 6.07
Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell (2004) 5.94
AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci U S A (2002) 5.93
Cachexia: a new definition. Clin Nutr (2008) 5.49
Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem (2002) 5.31
PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci U S A (2006) 5.28
Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell (2010) 5.23
Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem (1967) 5.20
Function of mitochondrial Stat3 in cellular respiration. Science (2009) 5.13
Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol (2012) 4.87
Fiber types in mammalian skeletal muscles. Physiol Rev (2011) 4.63
Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell (2001) 4.58
Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol Respir Environ Exerc Physiol (1984) 4.55
Autophagy is required to maintain muscle mass. Cell Metab (2009) 4.46
Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J Physiol (2003) 4.34
Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes (1998) 4.31
The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem (2006) 4.28
Mechanisms of cancer cachexia. Physiol Rev (2009) 4.03
Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol (2005) 3.93
A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes (2005) 3.84
hFis1, a novel component of the mammalian mitochondrial fission machinery. J Biol Chem (2003) 3.84
Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) (2008) 3.68
Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass. Am J Physiol (1998) 3.65
Cachexia in cancer patients. Nat Rev Cancer (2002) 3.63
Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab (2001) 3.45
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J (2012) 3.37
Invited Review: contractile activity-induced mitochondrial biogenesis in skeletal muscle. J Appl Physiol (1985) (2001) 3.35
Biochemical adaptations to endurance exercise in muscle. Annu Rev Physiol (1976) 3.31
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest (2004) 3.09
Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem (2005) 3.06
The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab (2007) 3.05
The underappreciated role of muscle in health and disease. Am J Clin Nutr (2006) 2.87
The adaptive response of skeletal muscle to increased use. Muscle Nerve (1981) 2.79
Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle. Biochem Biophys Res Commun (2002) 2.75
Mitochondrial fission and remodelling contributes to muscle atrophy. EMBO J (2010) 2.74
Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell (2005) 2.73
Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle. J Biol Chem (1997) 2.54
Role of myokines in exercise and metabolism. J Appl Physiol (1985) (2007) 2.52
Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J (2005) 2.48
The influence of activity on some contractile characteristics of mammalian fast and slow muscles. J Physiol (1969) 2.48
Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab (2013) 2.47
Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK. Genes Dev (2004) 2.39
A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell (2012) 2.35
Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem (2005) 2.33
Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab (1996) 2.30
Effects of exercise on mitochondrial content and function in aging human skeletal muscle. J Gerontol A Biol Sci Med Sci (2006) 2.23
Lack of exercise is a major cause of chronic diseases. Compr Physiol (2012) 2.19
A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab (2014) 2.18
Atrophy of the soleus muscle by hindlimb unweighting. J Appl Physiol (1985) (1990) 2.15
Intracellular signaling during skeletal muscle atrophy. Muscle Nerve (2006) 2.13
Cancer cachexia: understanding the molecular basis. Nat Rev Cancer (2014) 2.11
Coordination of metabolic plasticity in skeletal muscle. J Exp Biol (2006) 2.09
Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation. Am J Physiol Cell Physiol (2005) 2.08
Dependence of H2O2 formation by rat heart mitochondria on substrate availability and donor age. J Bioenerg Biomembr (1997) 2.06
Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J Physiol (2005) 1.94
Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2. Diabetes (2006) 1.91
Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol (2005) 1.83
Exercise, MAPK, and NF-kappaB signaling in skeletal muscle. J Appl Physiol (1985) (2007) 1.83
Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor. Proc Natl Acad Sci U S A (2001) 1.80
Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Metab Care (2010) 1.79
Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J Biol Chem (2007) 1.77
Histochemical and enzymatic comparison of the gastrocnemius muscle of young and elderly men and women. J Gerontol (1992) 1.74
Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab (1997) 1.73
Reactive oxygen species are signalling molecules for skeletal muscle adaptation. Exp Physiol (2009) 1.67
Androgen signaling in myocytes contributes to the maintenance of muscle mass and fiber type regulation but not to muscle strength or fatigue. Endocrinology (2009) 1.66
Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis. Cardiovasc Res (2007) 1.63
Mitochondrial shape changes: orchestrating cell pathophysiology. EMBO Rep (2010) 1.61
Tumour necrosis factor-alpha induces superoxide anion generation in mitochondria of L929 cells. Biochem J (1993) 1.61
NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest (2013) 1.60
TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J (2007) 1.60
p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting. Am J Physiol Cell Physiol (2009) 1.57
Cardiovascular adaptations to physical training. Annu Rev Physiol (1977) 1.57
Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol (2011) 1.55
The role of cytokines in cancer cachexia. Curr Opin Support Palliat Care (2009) 1.52
Human single muscle fibre function with 84 day bed-rest and resistance exercise. J Physiol (2004) 1.52
Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab (1998) 1.51
Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer (2004) 1.51
Mitochondrial fusion is increased by the nuclear coactivator PGC-1beta. PLoS One (2008) 1.50
Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice. FASEB J (2008) 1.46
Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Biochem Biophys Res Commun (2009) 1.45
Physical exercise stimulates autophagy in normal skeletal muscles but is detrimental for collagen VI-deficient muscles. Autophagy (2011) 1.44